Review of 2021, China's chemical drug report card and new topics

"The 21st century is the century of biology", with the improvement of science and technology and human cognition, biological drugs have received unprecedented attention, and many "new concept" drugs have been listed. In contrast, chemical drugs are slightly "lonely". Under the influence of policies such as national centralized procurement, consistency evaluation, and dynamic adjustment of medical insurance catalogs, is chemical drugs taking advantage of the trend to break through? Or drowned in the torrent of the times?

Macro, in 2020, when the new crown epidemic is raging, China's chemical drug market is stubbornly resistant, and the overall scale reaches 1.2 trillion yuan, which is little changed from 2019 and still remains the mainstay of the industry. At the micro level, the policy superimposed on the epidemic situation, forcing the strategic transformation of chemical drugs, some enterprises pay attention to "innovation" to increase R & D investment in the blue ocean market to seize the opportunity; another part of the enterprise is digging deep into the "moat", through the integration of upstream and downstream, continue to consolidate the advantages of the industrial chain and improve the comprehensive competitiveness.

2021 is the opening year of the "Fourteenth Five-Year Plan", and the development of chemical drugs in China is stable and good: first, the consistency evaluation of generic drugs has entered the harvest period; second, all kinds of new drugs have emerged in an endless stream, and the number of approvals has reached a new high; third, under the trend of internationalization, the chemical drug License In/Out has accelerated; fourth, the capital market has frequently thrown olive branches to the pharmaceutical field, and the IPO boom has made the new drug research and development boom boom.

Chemical drug strategy is related to enterprise survival, social development, people's health, how to open up the industrial chain blockages, formulate a chemical drug development strategy in the new era?

From December 24 to December 26, 2021, the "2021 (14th) China Pharmaceutical Strategy Conference" will be held in Datong, Shanxi Province, under the joint guidance of the Youth Working Committee of the Central Committee of the Chinese Peasants' and Workers' Party and the China General Institute of Pharmaceutical Industry Research, hosted by the China Pharmaceutical Industry Information Center, and jointly supported by the Datong Municipal People's Government, the Department of Industry and Information Technology of Shanxi Province, and the Shanxi Provincial Health Commission. At that time, we will lead all pharmaceutical people to think, speculate and summarize the current and future of domestic chemical drugs at the Chemical Drug Strategy Forum.